- Easy Tracking In The Watchlist
Biodexa Pharmaceuticals Plc American stock upgraded from Strong Sell Candidate to Sell Candidate after Friday trading session
(Updated on Jul 17, 2026)
No changes to the price of Biodexa Pharmaceuticals Plc American stock on the last trading day (Friday, 17th Jul 2026). During the last trading day the stock fluctuated 6.94% from a day low at $2.02 to a day high of $2.16. The price has fallen in 9 of the last 10 days and is down by -27.55% for this period.
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.11 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -28.40% during the next 3 months and, with a 90% probability hold a price between $1.51 and $2.65 at the end of this 3-month period.
BDRX Signals & Forecast
A buy signal was issued from a pivot bottom point on Thursday, July 16, 2026, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biodexa Pharmaceuticals Plc American stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.31 and $2.90. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Biodexa Pharmaceuticals Plc American stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.140 between high and low, or 6.94%. For the last week, the stock has had daily average volatility of 8.93%.
Biodexa Pharmaceuticals Plc American is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BDRX) For The Upcoming Trading Day Of Monday 20th
For the upcoming trading day on Monday, 20th we expect Biodexa Pharmaceuticals Plc American Depositary Shs to open at $2.10, and during the day (based on 14 day Average True Range), to move between $2.01 and $2.25, which gives a possible trading interval of +/-$0.231 (+/-11.49%) up or down from last closing price. If Biodexa Pharmaceuticals Plc American Depositary Shs takes out the full calculated possible swing range there will be an estimated 11.49% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $2.31, some $0.180 (8.45%) from the current price of $2.13, our system finds the risk reward not very attractive.
Is Biodexa Pharmaceuticals Plc American Depositary Shs stock A Buy?
Biodexa Pharmaceuticals Plc American holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score:
-4.837
Sell Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 20, 2026 - $2.10 ( 1.25%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
BDRX Performance
Trading levels for BDRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.24 | 5.33% |
| R2 | 2.19 | 2.81% |
| R1 | 2.16 | 1.26% |
| Price | 2.13 | |
| S1 | 2.05 | -3.76% |
| S2 | 2.02 | -5.32% |
| S3 | 1.96 | -7.83% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.66 | 24.88% |
| R2 | 2.59 | 21.60% |
| R1 | 2.31 | 8.45% |
| Price | 2.13 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Biodexa Pharmaceuticals Plc American Depositary Shs Stock.
Buy BDRX